NEXT LIQUID BIOPSY
Live / Registered — Registered (as of 09 Nov 2021)
What this means for you
Registered since 09 Nov 2021. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90080421
- Registration number
- 6556422
- Mark type
- Stylized text
- Filed
- 29 Jul 2020
- Published for opposition
- 22 Dec 2020
- Registered
- 09 Nov 2021
- Attorney of record
- Laura C. Miller
Goods and services
- Class 042 — Scientific and technological services: Providing genome sequencing, data analysis and interpretation, assay development and preparing, amplifying, labeling, detecting, analyzing and sequencing nucleic acids and other biological molecules, and research and design relating thereto, all in the field of bioinformatics, genomics and gene expression research and development
- Class 044 — Medical, beauty and agricultural services: Analysis of cells, tissues, gene expressions, gene sequences, genome annotation, transcriptome characterization, and genome mapping for medical diagnosis and treatment; Preparation of reports relating to gene expressions, gene and genome sequences, genome interaction and annotation, transcriptome analysis and characterization, and genome mapping for medical diagnosis and treatment
Owner
- Personalis, Inc., Menlo Park, CA, US
- Personalis, Inc., Menlo Park, CA, US
- Personalis, Inc., Menlo Park, CA, US
Prosecution history
- 09 Nov 2021 — REGISTERED-PRINCIPAL REGISTER
- 05 Oct 2021 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 04 Oct 2021 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 21 Sept 2021 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 21 Sept 2021 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 20 Sept 2021 — ASSIGNED TO LIE
- 14 Sept 2021 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 08 Sept 2021 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 08 Sept 2021 — NON-FINAL ACTION E-MAILED
- 08 Sept 2021 — SU - NON-FINAL ACTION - WRITTEN
- 20 Aug 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 19 Aug 2021 — STATEMENT OF USE PROCESSING COMPLETE
- 16 Aug 2021 — USE AMENDMENT FILED
- 19 Aug 2021 — SOU EXTENSION 1 GRANTED
- 16 Aug 2021 — SOU EXTENSION 1 FILED